Bioethics, Ltd. (BOTH)
OTCMKTS · Delayed Price · Currency is USD
0.0051
0.00 (0.00%)
At close: Nov 13, 2025

Bioethics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Income
-0.12-0.12-0.05-0.05-0.06-0.08
Net Income
-0.18-0.18-0.1-0.09-0.11-0.12
Earnings Per Share
-0.12-0.12-0.09-0.08-0.09-0.10
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
0.010.010000
Total Debt
0.590.590.440.420.40.37
Net Cash (Debt)
-0.57-0.57-0.44-0.42-0.39-0.36
Net Cash Growth
------
Net Cash Per Share
-0.38-0.38-0.39-0.36-0.35-0.32

Cash Flow & CapEx

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-0.15-0.15-0.02-0.03-0.03-0.07
Capital Expenditures
------
Free Cash Flow
-0.15-0.15-0.02-0.03-0.03-0.07
Free Cash Flow Growth
------